Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: Therapeutic implications for Parkinson's disease-Reference-Cited by-同舟云学术

Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: Therapeutic implications for Parkinson's disease

Published:2002-07-18 Issue:4 Volume:69 Page:559-566
ISSN:0360-4012
Container-title:Journal of Neuroscience Research
language:en
Short-container-title:J. Neurosci. Res.

Author:

Tai Kwok-Keung,Truong Daniel D.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Reference40 articles.

1. Hypoxia Induces the Activation of the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway in PC12 Cells

2. 1-Methyl-4-(2'-Ethylphenyl)-1,2,3,6-Tetrahydropyridine- Induced Toxicity in PC12 Cells Is Enhanced by Preventing Glycolysis

3. Chronic systemic pesticide exposure reproduces features of Parkinson's disease

4. KATP channel openers, adenosine agonists and epileptic preconditioning are stress signals inducing hippocampal neuroprotection

5. Alzheimer’s disease: a review concerning immune response and microischemia

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ion Channels and Metal Ions in Parkinson’s Disease: Historical Perspective to the Current Scenario;Methods in Molecular Biology;2024

2. Potassium Channels in Parkinson’s Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment;Pharmacological Reviews;2023-03-14

3. Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review;Parkinson's Disease;2019-11-23

4. Phosphoinositol metabolism affects AMP kinase-dependent K-ATP currents in rat substantia nigra dopamine neurons;Brain Research;2019-03

5. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson’s disease;Behavioural Pharmacology;2018-06